Hero

Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting

1

Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting

Celyad Announces October and November 2019 Investor Conference Schedule

2

Celyad Announces October and November 2019 Investor Conference Schedule

Celyad Announces Closing of $20 Million Global Offering

3

Celyad Announces Closing of $20 Million Global Offering

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad Announces October and November 2019 Investor Conference Schedule

Celyad Announces October and November 2019 Investor Conference Schedule

Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting

Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting

Celyad Announces Closing of $20 Million Global Offering

Celyad Announces Closing of $20 Million Global Offering

Discover all news

Carousel

Social Feed

Venez rencontrer Anne Moore, VP Corporate Strategy de Celyad, demain au Large & Midcap Event à Paris, un des évènem… https://t.co/cJdI314sC6

6 days ago

Venez rencontrer Anne Moore, VP Corporate Strategy de Celyad, demain au Large & Midcap Event à Paris, un des évènem… https://t.co/cJdI314sC6

Want to join a highly innovative company? We're hiring a Medical Director Hematology. https://t.co/rVol2XQjYX https://t.co/HnsuUH4e0J

1 week ago

Want to join a highly innovative company? We're hiring a Medical Director Hematology. https://t.co/rVol2XQjYX https://t.co/HnsuUH4e0J

Celyad Announces October and November 2019 Investor Conference Schedule $CYAD https://t.co/QBdIJfOQPj https://t.co/MF1bwxR2zL

2 weeks ago

Celyad Announces October and November 2019 Investor Conference Schedule $CYAD https://t.co/QBdIJfOQPj https://t.co/MF1bwxR2zL

Venez rencontrer Anne Moore, VP Corporate Strategy lors de la 1ère édition d’#InvestirDay ! C'est demain, Jeudi 3 o… https://t.co/sMeyyq95DZ

2 weeks ago

Venez rencontrer Anne Moore, VP Corporate Strategy lors de la 1ère édition d’#InvestirDay ! C'est demain, Jeudi 3 o… https://t.co/sMeyyq95DZ

Venez rencontrer Anne Moore, VP Corporate Strategy de Celyad, demain au Large & Midcap Event à Paris, un des évènem… https://t.co/cJdI314sC6

6 days ago

Venez rencontrer Anne Moore, VP Corporate Strategy de Celyad, demain au Large & Midcap Event à Paris, un des évènem… https://t.co/cJdI314sC6

Want to join a highly innovative company? We're hiring a Medical Director Hematology. https://t.co/rVol2XQjYX https://t.co/HnsuUH4e0J

1 week ago

Want to join a highly innovative company? We're hiring a Medical Director Hematology. https://t.co/rVol2XQjYX https://t.co/HnsuUH4e0J

Celyad Announces October and November 2019 Investor Conference Schedule $CYAD https://t.co/QBdIJfOQPj https://t.co/MF1bwxR2zL

2 weeks ago

Celyad Announces October and November 2019 Investor Conference Schedule $CYAD https://t.co/QBdIJfOQPj https://t.co/MF1bwxR2zL

Venez rencontrer Anne Moore, VP Corporate Strategy lors de la 1ère édition d’#InvestirDay ! C'est demain, Jeudi 3 o… https://t.co/sMeyyq95DZ

2 weeks ago

Venez rencontrer Anne Moore, VP Corporate Strategy lors de la 1ère édition d’#InvestirDay ! C'est demain, Jeudi 3 o… https://t.co/sMeyyq95DZ